Brazil-Italy joint lab focuses on Alzheimer’s drug development

This post was originally published on News-medical.net

You will shortly be re-directed to the publisher's website

A self-proclaimed Brazil-Italy collaboration enthusiast, researcher Laura Bolognesi created the B2AlzD2 Joint Lab at the Department of Pharmacy and Biotechnology of the Università di Bologna (UNIBO), the first Brazil-Bologna joint laboratory dedicated to the development of new drugs for the treatment of Alzheimer’s disease.